MICROBIOMA : UNA TERAPIA PER LA POUCHITE E LA COLITE ULCEROSA. UNA BUONA REVISIONE
The Microbiome as a Therapy in Pouchitis and Ulcerative Colitis Jean-Frédéric LeBlanc et al. Abstract The gut microbiome has been…
Approfondisci...
GEMELLI, IBD E MICROBIOMA: MARCATORI DELLA FLORA POTREBBERO PRECEDERE LA COMPARSA DELLE MANIFESTAZIONI CLINICHE
Healthy Cotwins Share Gut Microbiome Signatures With Their Inflammatory Bowel Disease Twins and Unrelated Patients Eelco C. Brand et al.…
CAMBIO SIMILARI NELLE IBD: INTERCAMBIABILITA’ NON EQUIVALE AD INTECAMBIABILE
The Automatic Substitution of Biosimilars: Definitions of Interchangeability are not Interchangeable Anita Afzali et al. Abstract In the USA, an…
COLITE MICROSCOPICA: LINEE GUIDA EUROPEE 2021
European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations Stephan Miehlke et al.…
EFFETTI COLLATERALI DEL TRAPIANTO FECALE: UNA REVISIONE IMPORTANTE
The Global Incidence of Faecal Microbiota Transplantation-related Adverse Events From 2000 to 2020 Cicilia Marcella et al. Abstract Background: Faecal microbiota…
PPI RIDUCONO EFFICACIA DI INFLIXIMAB NELLE IBD: UN’ OTTIMA META-ANALISI
The influence of proton pump inhibitor therapy on the outcome of infliximab therapy in inflammatory bowel disease: a patient-level meta-analysis…
BARRIERA MUCOSA: IL VERO AGENTE PROVOCATORE PER LE IBD
The intestinal barrier, an arbitrator turned provocateur in IBD Mehandru S, and Colombel JF Key studies published in 2020 demonstrate…
MICROBIOTA ED ASSE BRAIN-GUT: UNA REVIEW USA. DALLA MOTILITA’ AL TONO DELL’UMORE
The Microbiota-Gut-Brain Axis: From Motility to Mood Kara G. Margolis et al. Abstract The gut-brain axis plays an important role…
UN’ OTTIMA REVIEW DALLA GASTROENTEROLOGIA DELLA CATTOLICA SULL’ASSE GUT-BRAIN E MICROBIOTA: IBS vs IBD
The gut–brain axis in irritable bowel syndrome and inflammatory bowel disease. Angela Ancona et al. Introduction Gut microbiota (GM) has…
IBD E CLOSTRIDUM DIFFICILE
Infezione da Clostridium difficile e malattie infiammatorie croniche intestinali LUCIO CAPURSO1, MAURIZIO KOCH2 1Primario Emerito Gastroenterologia, Ospedale San Filippo Neri, Roma; 2Senior Director,…
L’aggiunta di AZA migliora la farmacocinetica di infliximab
Combination Therapy with Infliximab and Azathioprine Improves Infliximab Pharmacokinetic Features and Efficacy-a Post-hoc analysis.Colombel JF, Adedokun OJ, Gasink C, Gao…
Budesonide vs mesalazina nella colite linfocitica
Efficacy and Safety of Budesonide, vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic Colitis.Miehlke S, Aust D, Mihaly E,…
Metotrexate inefficace nel mantenere la remissione nella RCU
Methotrexate is not superior to placebo in maintaining steroid-free response or remission in ulcerative colitis.Herfarth H, Barnes EL, Valentine JF,…
Review sistematica su sicurezza della mesalazina nell’RCU
Systematic review: safety of mesalazine in ulcerative colitis.Sehgal P, Colombel JF, Aboubakr A, Narula N. Aliment Pharmacol Ther. 2018…
Nuove terapie orali nelle IBD
Review article: novel oral‐targeted therapies in inflammatory bowel disease.J. R. White,F. Phillips,T. Monaghan,W. Fateen,S. Samuel,S. Ghosh,G. W. Mora. APT First…
Monitoraggio della terapia con infliximab
Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases. Mitrev N, Vande…
Consensus sulle caratteristiche endoscopiche della colite ulcerativa associate a displasia
Endoscopic morphologic features of ulcerative colitis-associated dysplasia classified according to the SCENIC consensus statement.Sugimoto S, Naganuma M, Iwao Y, Matsuoka…
Review sistematica su infiammazione e rischio di cancro nella RCU
Impact of Mucosal Inflammation on Risk of Colorectal Neoplasia in Patients with Ulcerative Colitis: A Systematic Review and Meta-Analysis.Flores BM,…
Incremento dell’incidenza di UC in Svezia: 1963-2010
Changes in medical management and colectomy rates: a population-based cohort study on the epidemiology and natural history of ulcerative colitis…
FUSE può essere utile nella sorveglianza delle IBD long-standing?
Full-Spectrum Endoscopy Improves Surveillance for Dysplasia in Patients With Inflammatory Bowel Diseases.Leong RW, Ooi M, Corte C, Yau Y, Kermeen…
Anti-TNF associati a maggior rischio di complicanze post –operatorie
Association of Preoperative Anti-Tumor Necrosis Factor Therapy With Adverse Postoperative Outcomes in Patients Undergoing Abdominal Surgery for Ulcerative Colitis.Kulaylat AS,…
Trapianto fecale nella RCU : una review sistematica
Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis.Costello SP, Soo W, Bryant…
Biosimilari efficaci e sicuri
Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority…
5-ASA e rischio di CCR in pazienti affetti da IBD
Systematic review with meta-analysis: use of 5-aminosalicylates and risk of colorectal neoplasia in patients with inflammatory bowel disease.Bonovas S, Fiorino…
